Bank of Montreal
BMO
The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
Royal Bank of Canada
RY
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -233.57%-506.81K | 94.38%-187.93K | 73.34%-735.33K | 216.68%1.14M | 1,508.97%1.21M | 118.17%379.44K | -1,546.62%-3.35M | -114.90%-2.76M | -133.73%-976.8K | -31.08%75.18K |
Net income from continuing operations | -611.14%-571.53K | 60.89%-1.37M | 1.39%-20.09M | -723.98%-15.05M | 92.97%-1.62M | -55.41%111.81K | -6,082.33%-3.5M | -1,339.94%-20.38M | 324.30%2.41M | -10,425.74%-23.1M |
Operating gains losses | ---- | ---- | -1,149.57%-631.98K | --0 | ---- | -1,874.76%-631.98K | ---553.05K | -136.58%-50.58K | -92.10%36.76K | ---55.33K |
Depreciation and amortization | --0 | -45.72%191.19K | 642.94%1.73M | 473.59%863K | 280.48%222.45K | 2,587.91%333.97K | 3,083.73%352.22K | 425.19%232.41K | 551.49%150.46K | --58.47K |
Asset impairment expenditure | ---- | ---- | -59.15%12.24M | 46.40%12.24M | --0 | ---- | ---- | --29.96M | --8.36M | --21.6M |
Deferred tax | ---- | ---- | --1.96M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non cashItems | 235.91%360.62K | 46.34%464.38K | 91.74%-984.07K | 92.66%-1.01M | -67.96%565.57K | -638.05%-265.33K | 871.07%317.33K | -11,957.73%-11.92M | ---13.77M | --1.77M |
Change In working capital | -135.61%-295.91K | 1,600.89%621.2K | 1,015.72%5.52M | 38.98%2.55M | 1,183.80%2.11M | 135.08%830.97K | -71.70%36.52K | -151.40%-602.61K | 9,409.58%1.83M | -130.63%-194.28K |
-Change in receivables | ---- | ---- | 277.97%2.62M | -99.05%12.83K | 612.90%4.05M | ---- | ---- | -749.32%-1.47M | 2,705.49%1.35M | -571.90%-790.3K |
-Change in prepaid assets | ---- | ---- | 156.08%411.62K | 388.50%2.14M | ---696.99K | ---- | ---- | ---734K | -353.22%-741.16K | --0 |
-Change in payables and accrued expense | ---- | ---- | 55.27%2.49M | -67.70%394.12K | -309.87%-1.25M | ---- | ---- | 2,510.82%1.6M | 523.39%1.22M | 211.65%596.02K |
Interest paid (cash flow from operating activities) | ---- | ---96.32K | ---472.49K | ---411.6K | ---60.9K | ---- | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -233.57%-506.81K | 94.38%-187.93K | 73.34%-735.33K | 216.68%1.14M | 1,508.97%1.21M | 118.17%379.44K | -1,546.62%-3.35M | -114.90%-2.76M | -133.73%-976.8K | -31.08%75.18K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 95.62%-85.23K | -131.80%-8.57M | -210.06%-1.83M | -213.26%-4.61M | 84.63%-182.22K | -333.51%-1.94M | -50.23%-3.7M | 55.90%-590.9K | -31.31%-1.47M |
Capital expenditure reported | --0 | 89.23%-85.23K | -51,618.86%-3.62M | -116.64%-426.61K | -117.75%-2.21M | 84.63%-182.22K | -76.39%-791.26K | ---7K | --2.56M | ---1.02M |
Net PPE purchase and sale | ---- | ---- | ---522.97K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net intangibles purchas and sale | ---- | --0 | ---- | ---- | ---- | ---- | ---7K | ---- | ---- | ---- |
Net investment purchase and sale | --0 | --0 | ---3.56M | ---24.48K | ---2.39M | --0 | ---1.15M | --0 | --0 | --0 |
Net other investing changes | ---- | ---- | 76.74%-858.07K | ---- | ---- | ---- | ---- | -114.45%-3.69M | -425.88%-3.16M | ---454.28K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | 95.62%-85.23K | -131.80%-8.57M | -210.06%-1.83M | -213.26%-4.61M | 84.63%-182.22K | -333.51%-1.94M | -50.23%-3.7M | 55.90%-590.9K | -31.31%-1.47M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 551.29%613.86K | 121.73%262.25K | -77.76%2.8M | -92.94%541.78K | 818.52%3.49M | -102.99%-136.02K | -1.21M | 213.50%12.6M | 811.51%7.68M | -83.58%379.52K |
Net issuance payments of debt | --0 | --0 | -61.91%1.76M | --0 | --2.99M | -102.89%-136.02K | ---1.21M | 3,127.61%4.63M | -18.34%-79.22K | --0 |
Net common stock issuance | 61,385,900.00%613.86K | ---- | -89.98%801.91K | ---- | ---- | --1 | ---- | 86.36%8M | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | -68.01%256.09K | -39.16%256.09K | --0 | ---- | ---- | 1,027.46%800.43K | --420.91K | --379.52K |
Net other financing activities | ---- | --262.25K | 98.02%-16.22K | 22.43%-516.22K | --500K | 100.00%-1 | ---- | -331.46%-821.25K | ---665.46K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 551.29%613.86K | 121.73%262.25K | -77.76%2.8M | -92.94%541.78K | 818.52%3.49M | -102.99%-136.02K | ---1.21M | 213.50%12.6M | 811.51%7.68M | -83.58%379.52K |
Net cash flow | ||||||||||
Beginning cash position | -17.46%55.66K | -98.99%66.57K | 1,488.08%6.56M | -52.33%217.17K | -91.26%128.64K | -65.60%67.44K | 1,488.08%6.56M | 203.76%413.34K | -65.72%455.57K | 5,057.52%1.47M |
Current changes in cash | -187.68%-53.66K | 99.83%-10.91K | -205.64%-6.5M | -102.47%-150.6K | 108.71%88.54K | -95.20%61.2K | -2,889.46%-6.5M | 2,118.37%6.15M | 767.16%6.11M | -178.13%-1.02M |
End cash Position | -98.44%2.01K | -17.46%55.66K | -98.99%66.57K | -98.99%66.57K | -52.33%217.17K | -91.26%128.64K | -65.60%67.44K | 1,488.08%6.56M | 1,488.08%6.56M | -65.72%455.57K |
Free cash from | -356.98%-506.81K | 93.41%-273.16K | -76.41%-4.88M | -88.02%190.17K | -6.63%-1M | 106.02%197.22K | -1,806.71%-4.14M | -115.45%-2.77M | 479.89%1.59M | -962.88%-941.21K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.